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INTRODUCTION
 Vitamin D deficiency is common in general 
population.1 About one billion people suffer from 
vitamin D deficiency around the globe.2 Adequate 
vitamin D is essential for maintaining skeletal 
growth owing to its central role in calcium and 
phosphate metabolism.3 Vitamin D ensures the 
mineralization of the organic matrix of bone, and 
also mediates the release of calcium and phosphate 
from bone to achieve mineral homeostasis.4 
Calcium and phosphate not only helps in achieving 
peak bone before the onset of menopause and age 
related decline in bone formation but also provide 
protection against bone loss and fractures.5
 Low levels of vitamin D have been shown to have 
adverse effects on calcium metabolism, osteoblastic 
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ABSTRACT
Objective: To compare the serum levels of vitamin D, vitamin D binding protein (VDBP) calcium and 
phosphate in normal, osteopenic and osteoporotic postmenopausal women categorized on the basis of 
bone mineral density (BMD) scores.
Methods: A cross sectional study carried out from May 2017 to August 2018. BMD measured by Dual energy 
X-ray Absorptiometry categorized women (aged 20- 70 years) into normal (n=37) (T score ≥ -1.0) osteopenic 
(n=25) (-2.5< T score, < -1) and osteoporotic (n= 26) (T score < -2.5) according to WHO classification. Serum 
concentrations of vitamin D, VDBP, calcium, phosphate analyzed by enzyme linked immunosorbent assay 
were compared by Analysis of Variance
Results: In normal females higher levels of vitamin D and VDBP were observed [15.82 (8 - 69.18), 469.9 
(269.57 - 875.55)] vs. osteopenic [(7.45 (4.66 - 15.1), 296.05 (232.58 - 420.23)] and osteoporotic women 
[(7.25 (3.97 - 17.49), 272.94 (202.23 - 351.24)]; [median interquartile range]; p value < 0.0001.
Conclusion: Vitamin D and VDBP are linked with bone health and estimation of VDBP appears to be a 
valuable tool for the assessment of increased bone loss and possible risks of bone fractures especially in 
postmenopausal women.
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activity, matrix ossification, bone mineral 
density (BMD). Deficiency of vitamin D leads to 
the development of osteomalacia (incomplete 
mineralization of osteoid) in adults and rickets 
in children. Chronic insufficiency of vitamin D 
leads to secondary hyperparathyroidism with 
increased bone turnover and decreased BMD. The 
progressive bone loss exacerbates both osteopenia 
and osteoporosis and increased risk of fragility 
fractures especially in elderly individuals.6
 Concentration of vitamin D within the body is 
affected by various factors including age, body 
weight, ethnicity, genetic polymorphisms and 
vitamin D–binding protein (VDBP), the primary 
vitamin D carrier protein.7
 Majority of vitamin D in serum is bound to 
VDBP (80-90%), and also bound to albumin and 
chylomicrons (10 – 15%) at lower levels and affinity, 
very small fraction is free (<0.1%) and is biologically 
active. Vitamin D bound to VDBP, facilitates the 
access of vitamin D to various tissues and cells and 
regulates the total amount of vitamin D available 
for the organism. It protects vitamin D metabolites 
from hydroxylase-mediated catabolism and 
therefore act as vitamin D reservoir.8 The hepatic 
synthesis of VDBP is stimulated by estrogen as seen 
in various studies that showed increase in serum 
concentration of VDBP in pregnant females and in 
women taking exogenous estrogen.9
  Menopause either involutional or estrogen 
related is associated with increased bone turnover 
and risk of osteoporotic fracture owing to multiple 
factors including low levels of total circulating 
vitamin D and VDBP.10 The current study was 
designed to compare the serum levels of vitamin D, 
VDBP, calcium, phosphate along with biophysical 
parameters in normal, postmenopausal osteopenic 
and osteoporotic women and also to examine the 
relationship between vitamin D, VD, BP and BMD 
in all three groups.
METHODS
 This cross-sectional study comprised of 88 healthy 
women (aged 20-70 years). Study was conducted in 
the Department of Biological & Biomedical Sciences 
Aga Khan University from May 2017 - August 2018 
after approval from Ethical Committee of Aga Khan 
University (4146-BBS-ERC-16). Combined preva-
lence of osteoporosis and osteopenia is 82%.11We 
calculated 57 sample size for osteopenic and osteo-
porotic group using infinite formula for sample size 
calculation for osteoporosis and osteopenic groups 
with 95% confidence level (1.96), prevalence 82% 
and margin of error 10% in the following formula;
n=(Z^2 pq)/e^2
n=((1.96)^2 (0.82)(0.18))/ (0.1) ^2
n=57
We collected data of 57 subjects, but due to drop 
out of 6 subjects, we compared 51 postmenopausal 
women with minimum significant normal (37) 
subjects
Where: z = standard normal deviation set at 95% 
confidence level
p = percentage picking a choice or response
c = confidence interval
 The subjects were recruited from the community, 
motivated to come to AKU where their free DEXA 
scans were done and blood samples were acquired 
after taking written informed consent from each 
participant. Weight was recorded digitally to the 
nearest 0.1kg while height was recorded to the 
nearest 0.1cm using seca 217 stadiometer. Body 
mass index (BMI) was calculated as the ratio of 
weight (kg) and height (m2).
 Subjects were recruited by organizing health 
camps in different districts of Karachi through con-
venient sampling (Fig.1). Participants with history 
of premature menopause, vertebral fractures or suf-
fering from systemic illness like hyperthyroidism, 
hyperparathyroidism, renal failure or taking any 
medications known to affect bone metabolism like 
bisphosphonates, calcium, vitamin D supplements, 
calcitonin, hormone replacement therapy and 
anabolic steroids were excluded from the study. 
Women were further categorized on the basis of 
BMD measurements according to WHO classifica-
tion into, normal (T score ≥ -1.0) (n=37) osteopenic 
(n=25) (-2.5< T score, < -1) and osteoporotic (n= 26) 
(T score < -2.5).12 BMD in (gm/cm2) was measured 
by DEXA scan by Hologic discovery A (S/N 80855). 
Sites of measurement were hip, femoral neck and 
spine (L1-L4).
 Serum vitamin D, VDBP, calcium and Phosphate 
were measured by solid phase enzyme amplified 
sensitivity immunoassay method (commercial kit 
DIA source immunoassay, Belgium) kitCat≠95503 
for vitamin D, kit Cat ≠ 97145 for VDBP). Calcium 
and phosphate were measured by kit Cat≠ SP 
1001061, and kit Cat ≠ SP1001150 respectively. Cut 
off values for deficient, insufficient and sufficient 
vitamin D levels were taken to be <20ng/ ml, 20-
30ng/ml and >30ng/ml respectively.13 Statistical 
analyses were done using Statistical Package 
for Social Sciences SPSS (version 21). Baseline 
characteristics of the participants were analyzed 
by descriptive statistics (mean± SD). Statistical 
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comparison was performed using ANOVA, post 
hoc Tukey HSD test was then applied. All p-values 
< 0.05 were taken as significant.
RESULTS
 Total 88 healthy women were included in this 
study, out of which 37 were normal, 25 were 
osteopenic and 26 were osteoporotic women as 
per estimation of BMD. In normal group (n=37) 
premenopausal women were (n=30, 11.1%), 
and postmenopausal women were (n=7, 2.5%), 
whereas osteopenic (n=25) and osteoporotic 
group (n=26) comprised only of postmenopausal 
women.
Vitamin D and Vitamin D-Binding Proteins in Post menopausal females
Table-I: Comparison of baseline characteristics of the participants.
Normal (37) Osteopenic (25) Osteoporotic (26) P value
Age (years) 36.43 ±13.71 52.48 ±10.324 58.577±5.021**^^ <0.001
Height (centimeters) 157.21 ±5.678 155.256±4.792 154±5.546 0.06
Weight 62.8 ± 12.886 67.12±11.641 60.904±9.846 0.15
BMI kg/m2 25.319 ±5.463 28.132±5.073 26.262±4.943 0.11
Duration of Menopause (years) 8.286±3.717 7.885±3.953 0.16
Vitamin D (ng/ml)
Median (Interquartile Range) 
15.82 (8 - 69.18) 7.45 (4.66 - 15.1) 7.25 (3.97 - 17.49) ^ 0.06
VDBP (ng/ml)
Median (Interquartile Range)
469.9 (269.57 - 875.55)
296.05 (232.58 - 
420.23)
272.94 (202.23 - 351.24*^ 0.01
Calcium mg/dl 7.643±1.37 7.3±1.1216 7.86±1.559 0.35
Phosphate mg/dl 4.385±1.084 4.572± 1.033 4.457±1.11 0.80
Dexa Hip score -0.543±0.803 -0.728±0.648 -1.95± 0.62 <0.001
Dexa score spine 0.797±0.65 -1.556±1.023 -2.95±1.047 <0.001
Dexa Hip femoral neck 0.927±0.705 -1.476±0.63 -2.527±0.556 <0.001
Values are expressed in mean±Standard deviation or Median (Interquartile range)
Analysis of variance was used to compare means between groups.
* p value<0.05 is significant in osteoporotic group as compared to osteopenic
**p value<0.001 is significant osteoporotic group as compared to osteopenic
^ p value<0.05 is significant in osteoporotic group as compared to normal
^^ p value<0.001 is significant in osteoporotic group as compared to normal.
Fig.1: Patient selection flow chart.
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 The characteristics of study participants are 
shown in Table-I. Serum levels of vitamin D and 
VDBP were significantly different across groups 
and were on higher side in normal compared to 
osteopenic and osteoporotic group (p-value < 
0.0001). 
 The Fig.2 describes the distribution of normal, 
osteopenic and osteoporotic groups on the basis of 
cut off values of vitamin D (deficiency < 20ng/ml, 
insufficiency 20-30ng/ml, sufficiency > 30ng/ml.13 
It shows that in normal group (n=37) the number 
of females deficient, insufficient and sufficient 
for vitamin D levels were 35%, 22% and 43% 
respectively. Vitamin D levels in normal women 
differed significantly from osteopenic group 56% 
deficient, 28% insufficient and 16% sufficient. In 
osteoporotic group 62% females were deficient, 23% 
were insufficient and 15% had sufficient Vitamin D 
levels respectively (p value <0.0001).
 Fig.3 describes the representation of median 
values of VDBP in all study groups. In normal group, 
serum VDBP levels were higher (594.583±397.601 ng/
ml) compared to osteopenic (348.524±183.501 ng/
ml) and osteoporotic group (278.934±109.582ng/
ml) (p value < 0.0001).
DISCUSSION
 Hypovitaminosis D is common worldwide and 
affects children and elderly people predominantly 
postmenopausal women.14,15 Our study shows that 
serum levels of vitamin D and VDBP were lower 
in postmenopausal osteopenic and osteoporotic 
women compared to the normal group. Similar 
findings can be compared by another study 
which explained lower levels of estrogen as a 
contributing factor for low vitamin D concentration 
in postmenopausal women.16 Present study 
also showed higher mean age in osteoporotic 
group compared to the normal group which also 
suggests an age-related phenomenon responsible 
for decreased vitamin D levels in these women. 
Impaired function of the enzyme 1 α hydroxylase 
required for the formation of active vitamin D (1, 25 
dihydroxycholicalciferol) and increased metabolic 
clearance of vitamin D metabolites is responsible 
for a decline in vitamin D levels seen in elderly 
postmenopausal osteoporotic women.17 Results of 
this study also showed that BMD measured at hip, 
spine and femoral neck was also significantly lower 
in postmenopausal osteopenic and osteoporotic 
women having lower serum vitamin D levels 
compared to the normal group. Similar finding are 
reported by Nakamura et al showing decline in 
BMD at femoral neck in subjects having low vitamin 
D levels compared to those having adequate levels 
of vitamin D.18
 Serum calcium and phosphate were low in 
all three study groups, as shown in our results; 
however no significant difference was seen among 
three groups. This may be related to either low 
intake or impaired absorption of minerals seen in 
vitamin D deficiency or inadequacy.19
 Among postmenopausal osteoporotic women the 
prevalence of vitamin D deficiency was 62% using a 
cut off value <20ng/ml and insufficiency was 23%, 
using a cut-off of 20-30ng/ml. Previous literature 
Rafat Murad et al.
Fig.2: Vitamin D levels in normal, osteopenic and 
osteoporotic females on the basis of cut off values 
deficient, insufficient and sufficient vitamin D levels were 
taken to be<20ng/ ml, 20-30ng/ml and >30ng/ml.
Fig.3: Comparison of Vitamin D-binding 
proteins in the study groups.
has reported increased serum levels of parathyroid 
hormone in subjects having low serum vitamin 
D levels < 20ng/ml causing decrease in calcium 
absorption and serum calcium concentration, 
which is maintained as the expense of increased 
parathyroid secretion, referred to as secondary 
hyperparathyroidism.20 Several observational 
studies have reported the association of serum 
vitamin D levels with osteoporotic fractures. A 
cohort study conducted by Tanaka et al comprising 
of 1470 postmenopausal women revealed that those 
with serum vitamin D levels < 25ng/ml showed 
a significant higher risk of long bone fracture.21 
Another study comprising of 1262 postmenopausal 
women have reported higher incidence of 5 year 
total fracture risk among postmenopausal women 
having basal serum vitamin D levels <10 ng/ml 
followed by those whose vitamin D levels were 
between 10-20ng/ml and 20-30ng/ml and was 
lowest in those having > 30ng/ml.22
 Various factors are responsible for maintaining 
vitamin D status including VDBP which is 
responsible for maintaining the availability and 
regulation of serum vitamin D levels. This study 
results have shown that VDBP concentration was 
lower in osteoporotic women compared to normal 
group of women. Others have also shown decreased 
levels of VDBP in females than in males, which 
could be due to differences in estrogen levels.23 
Increased serum VDBP levels have also been 
reported in women receiving hormone replacement 
therapy, oral contraceptives and in pregnancy.24 
Similarly concomitant decreased concentration 
of VDBP and vitamin D in postmenopausal 
osteoporotic women as reported in our study, might 
be due to physiological adaptation to maintain 
free vitamin D levels or due to a compensatory 
mechanism of reduced hepatic synthesis of VDBP 
as result of decreased vitamin D in postmenopausal 
osteoporotic women.25
 Our study also highlighted increased serum 
levels of VDBP in normal premenopausal women 
compared to postmenopausal osteoporotic women. 
This can be due to the deficiency of estrogen 
hormone in postmenopausal women, which is 
required in higher concentration to raise serum 
levels of VDBP as identified in previous estrogen 
administration studies and during pregnancy.26
 This study results have identified the role of 
vitamin D and VDBP for evaluating the risk of 
osteoporosis and osteoporotic related fractures 
in postmenopausal women, but due to limited 
number of patients, we could not draw conclusions 
from the findings. Further studies with large sample 
size are needed to assess the role of vitamin D and 
VDBP in the prediction of loss of BMD and risk of 
fragility fractures especially in postmenopausal 
osteoporotic women. We have not related our 
results with exposure to sun, latitude, season, time 
of day, and atmospheric components as all subjects 
were permanent residents of Karachi. Also initial 
screening at camps ruled out subjects positive for 
certain other factors like obesity, chronic illnesses 
and smoking etc.
CONCLUSION
 Serum levels of vitamin D and VDBP were lower 
in osteopenic and osteoporotic post-menopausal 
women as compared to the normal females who 
reflected normal bone architecture as evidenced 
by normal BMD. Vitamin D and VDBP are thus 
important for incremental increase in BMD, 
furthermore recommend that VDBP may be used as 
a valuable tool to identify the risk of osteoporotic 
fractures associated with decline in BMD especially 
in postmenopausal women.
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